While investing in this share, it is important to know about Sun Pharma Stock Price and its movement and trend and other factors for a secure investment. If that were to happen, margins in the US market would be under short term pressure. Get Latest Business News , Stock Market Updates and Videos ; Check your tax outgo through Income Tax Calculator and save money through our Personal Finance coverage. DATA SOURCES: TickerPlant (for live BSE/NSE quotes service) and Dion Global Solutions Ltd. (for corporate data, historical price & volume, F&O data). Who is raising the stake and who is exiting? Mutual Funds have increased holdings from 10.52% to 10.71% in Sep 2020 qtr. By using this site, you agree to the Terms of Service and Privacy Policy. Get the latest Sun pharma shares news, videos and headlines. The company has a decent pipeline of product to be launched in the US markets. 39 (3) - Details of Loss of Certificate / Duplicate Certificate, Compliances-Certificate under Reg. day, calculated based on price range of the previous trading day. Reliance Industries rally not over yet. Good level to enter now, dont miss this opportunity... aisa mauka baar baar nahin milta.. http://rebrand.ly/alerts2021, . Nov 12 2020 12:11 PM, Why Lupinu2019s Solosec is a cautionary tale for the much-hyped speciality drug business DISCLAIMER: Any and all content on this website including tools/analysis is provided to you only for convenience and on an “as-is, as- available” basis without representation and warranties of any kind. (as of last trading session), Stock generated 4.6% return as compared to Nifty Pharma which gave investors 36.99% return over 3 year time period. Mirae Asset Emerging Bluechip Fund Direct-Growth, ICICI Prudential Bluechip Fund Direct-Growth. It remains to be seen if this trend will continue in the post COVID-19 period also. It is also the 1 year high and low of the security. The dividend declared by a company is usually declared as a percentage of face value. It completed its corrective wave (2) at 450 levels around September. For reprint rights: Sun Pharmaceutical Industries Ltd., incorporated in the year 1993, is a Large Cap company (having a market cap of Rs 144991.81 Crore) operating in Pharmaceuticals sector. Sun Pharmaceuticals SUNPHARMA share price forecast & targets for Intra Day are 591.15, 594.87, 587.43 on the downside, and 608.4, 612.12, 621.93 on the upside. While at the time of the announcement the deal was … Best time for investment in pharma more detls. Sun Pharma shares gain more than 4% intraday after announcing plans to acquire Ranbaxy Laboratories. previous trading month. Reliance Industries rally not over yet. Show More, Nifty 50, S&P BSE Sensex, Nifty 100, + 28 more, Sun Pharma Advanced Research Centre (SPARC),Tandalja,Vadodra, Gujarat - 390020, Sun Pharmaceutical Industries Ltd. share price moved down by -0.45% from its previous close of Rs 607.05. Its current market capitalisation stands at Rs 144463.96 Cr. Sun pharma has broken its 3-year downward trendline. Sun Pharma latest to sell COVID-19 drug favipiravir in India. Sun Pharmaceutical Industries Ltd. was incorporated in the year 1993. RSI has already passed its complexion point. Focus back on active pharmaceutical ingredients. *Transaction of a minimum quantity of 500,000 shares or a minimum value of Rs 5 crore. DONT MISS THIS TIME... http://rebrand.ly/alerts2021, . Book value represents the value arrived at by subtracting the total liabilities from the total assets of the company. Stock / Share Price - Get live NSE/ BSE Share Price of Sun Pharma.Inds. Resistance level for the month, calculated based on price range of the Sun Pharma share price closed at Rs 567.05 , up by 1.85 points or 0.33%. Read research reports, investor presentations, listen to earnings call and get recommendations from the best minds to maximise your gains. Note : Support and Launch of new-age specialty products will drive this growth. (Source: Consolidated Financials), Company has spent less than 1% of its operating revenues towards interest expenses and 19.38% towards employee cost in the year ending Mar 31, 2020. (Source: Consolidated Financials), Company has used Rs 2588.84 cr for investing activities which is an YoY increase of 280.01%. Nifty may touch 13,640 by December 2021: Nomura Copyright © 2021 Bennett, Coleman & Co. Ltd. All rights reserved. SUN PHARMA ADV. Company has S R B C & Co. LLP as its auditors. This represents the highest and lowest price touched by the security during the past 52 weeks or 1 year including today. Note : Support and Resistance level for the month, calculated day, calculated based on price range of the previous trading day. 2004 - Sun Pharma acquires common stock and options from 2 large shareholders of Caraco, increasing stake to over 60% from 44% at a total outlay of about $42 … Share Price Down by 5%; BSE 500 Index Down 1.0% - 06 Jan 2021 Sun Pharma extends gain after Q2 earnings - 04 Nov 2020 BSE Announcements from Sun Pharmaceutical Industries Ltd. Sun Pharmaceutical Industries Ltd. key Products/Revenue Segments include Pharmaceuticals which contributed Rs 11906.74 Crore to Sales Value (95.01 % of Total Sales) and Other Operating Revenue which contributed Rs 625.19 Crore to Sales Value (4.98 % of Total Sales)for the year ending 31-Mar-2020. Nov 04 2020 10:11 AM, . Sun Pharma Specialty business is witnessing improved traction. August 29, 2019, 11:08 IST explore: Business Copyright © e-Eighteen.com Ltd All rights resderved. Sun Pharmaceutical Industries Ltd. share price moved down by -0.18 % from its previous close of Rs 604.25. Get all the information on mutual fund schemes and the names of institutions which invested in a company. Let's reshape it today, Hunt for the brightest engineers in India. Note : Support and Resistance level for the week, calculated The company’s top management includes Mr.Dilip S Shanghvi, Mr.Gautam Doshi, Mr.Israel Makov, Mr.Kalyanasundaram Subramanian, Mr.Sailesh T Desai, Mr.Sudhir V Valia, Mr.Vivek Chaand Sehgal, Ms.Rekha Sethi. ), Strong Performer: based on price range of the previous trading week. , latest research reports, key ratios, fiancials and stock price history of Sun Pharma… We at moneycontrol are continually attempting to improve our products and what’s more, carry the best to our users! Stock market update: Nifty Pharma index slips 1%; Divi's Lab sheds 2%, 5 pharma stocks that more than doubled money in one year, Stocks in the news: HDFC, Larsen & Toubro, JSPL, Sun Pharma and SBI, Compliances-Reg. Sun Pharmaceutical Industries Ltd. share price moved down by -0.16 % from its previous close of Rs 604.40. Reproduction of news articles, photos, videos or any other content in whole or in part in any form 74 (5) of SEBI (DP) Regulations, 2018, Buy Sun Pharma, target price Rs 650: Motilal Oswal, All figures in Rs Cr, unless mentioned otherwise, MANAGEMENT DISCUSSION AND ANALYSIS (FY 2019-20), Digital technologies - In post covid world, will it or will it not. Dividend Yield calculates the amount of full year dividend declared by a company as a percentage of the current market price of a stock. Get India stock market quotes, stock quote news india, latest share prices for SUN.NS Good level to enter now, dont miss this opportunity... aisa mauka baar baar nahin milta.. http://rebrand.ly/alerts2021 Language English . Pick up in the US specialty business coupled with likely traction from a sturdy new product launch pipeline, would fuel the growth of the US business. Which stock to buy and why? Sun pharma at the resistance zone. This is the ranking of a company within its sector based on MCap or Market capitalization. As of September 2017, Sun Pharma promoters held a 54.38 per cent stake in the company, while the remaining 45.62 per cent was with the public. You will now receive notification when someone reply to this message. These intraday share price levels are calculated using pivot point calculations and valid only for tomorrow's session on a 5-15 minute chart. Book value is also known as Net Asset Value of a company. Company's annual revenue growth of 11.24% outperformed its 3 year CAGR of 1.57%. RES. Stock with good financial performance alongside good to expensive valuation, but lacks price momentum as suggested by technical indicators. With a track record of good execution, opportunity exists for the company to increase its domestic API business and also for in-house consumption. View more, . *A bulk deal is a trade where total quantity of shares bought or sold is more than 0.5% of the equity shares of a company listed on the exchange. Is the company as good as it looks? Sun Pharmaceutical Industries' (SPIL) 2QFY21 revenue at Rs85,531mn is up 12.8% QoQ and 5.3% YoY given the easing of lockdowns across the world. For the quarter ended 30-09-2020, the company has reported a Consolidated sales of Rs 8458.77 Crore, up 13.28 % from last quarter Sales of Rs 7467.19 Crore and up 6.41 % from last year same quarter Sales of Rs 7949.19 Crore Company has reported net profit after tax of Rs 1948.38 Crore in latest quarter. previous trading week. On dividing this value with the total number of shares outstanding for the company, we can arrive at book value per share. This Mumbai Stock Market & Finance report, prediction for the future: You'll find the Sun Pharmaceutical Industries share forecasts, stock quote and buy / sell signals below.According to present data Sun Pharmaceutical Industries's Sun Pharmaceutical Industries Ltd shares … US sales contributed 32 per cent of the overall sales in FY-20, even though pricing pressures in the US markets has been receding. Sun Pharma Share – Conclusion. Digital technologies are being leveraged significantly for patient-to-doctor connect currently since a face-to-face consultation may not be possible due to COVID-19. Company analysis giving insights of fundamentals, earnings, relative valuations, risk, price momentum and inside trading. This unique "area" or candle chart enables you to clearly notice the movements of this Sun Pharma share within the last hours of trading, as well as providing you with key data such as the daily change, high and low prices. Face value of a stock is the value ascribed to the stock as per the balance sheet of the company. As on 30-09-2020, the company has a total of 2,399,334,970 shares outstanding. Make an informed investment decision with advanced AI-based features like SWOT analysis, investment checklist, technical ratings and know how fairly the company is valued. So far, it has acted like a tired lion however, it seems the lion is ready to claim the kingship all over again. Increasing overall market size but pricing pressure might continue. *Disclosures under SEBI Prohibition of Insider Trading Regulations, 2015, *Disclosures under SEBI SAST (Substantial Acquisition of Shares and Takeovers) Regulations, 2011. Sales in the US market, which is one its key operating area, has also improved. This is a ratio arrived at by dividing the current market price of a stock by its latest (annual or annualized) earnings per share. Institutional Investors have increased holdings from 32.81% to 32.84% in Sep 2020 qtr. Average price decline of -6.25% within 7 weeks of Bearish signal in last 10 years, Average price decline of -2.86% within 7 days of Bearish signal in last 5 years, Average price decline of -3.66% within 10 days of Bearish signal in last 10 years, Stock gave a 3 year return of 4.6% as compared to Nifty 100 which gave a return of 31.44%. Sun Pharma Shares Jump 4.5% as Sebi Probe Finds No Merit in Fraud Charges. Stay updated with the latest block and bulk deals to gauge big investor mood and also keep an eye on what Insiders are doing. Marg, Vikhroli (West), Your feedback matters! The stock has corrected 33% in the last one year. MCap or Market capitalization of a stock is calculated by multiplying the total number of shares outstanding of that particular stock with its current market price. Tell us what we got right and what we didn’t? Sun Pharma scrip was trading 1.43 % higher at Rs 580.10, while shares of Ranbaxy Laboratories were trading 5.14% lower at Rs 436. What do you like about the new Stock Price page? Marg, Vikhroli (West)","address2":"","address3":"","address4":"","telephone":"022-49186270, 49186200","fax":"022-49186060","email":"rnt.helpdesk@linkintime.co.in","internet":"http:\/\/www.linkintime.co.in","city":"Mumbai","state":"Maharashtra","pincode":"400083"},"listing":[{"name":"BSE 100","value":"Yes"},{"name":"BSE 200","value":"Yes"},{"name":"SENSEX","value":"Yes"},{"name":"CNX MIDCAP 200","value":"No"},{"name":"NIFTY 50","value":"Yes"},{"name":"BSE 500","value":"Yes"}],"details":{"bseId":"524715","nseId":"SUNPHARMA","series":"EQ","isinid":"INE044A01036"}}}. The book value itself is arrived at by dividing the net worth of a company by the total number of shares outstanding of the company at that time. The Economic Times Digital Payments Forum, Closing Cash & Cash Equivalent Growth (%), Book closure from Aug 21, 2020 to Aug 27, 2020, Bonus Ratio: 1 share(s) for every 1 shares held, Bonus Ratio: 2 share(s) for every 1 shares held. Detailed analysis of what to do in Intraday & BTST tips for Sun Pharmaceuticals are here 52 week High of Sun Pharmaceuticals: 628.00 Higher the market capitalization of a company, higher the rank it is assigned. Price to Book represents the ratio of current market price of a stock to its book value per share. Board of Directors; Acquisitions & Joint Ventures; Research & Development; Manufacturing; Products; Quality Resistance level for the week, calculated based on price range of the Sun Pharmaceutical Industries Ltd. (SUN) Access our live advanced streaming chart forSun Pharmaceutical Industries Ltd. Share, free of charge. Reuters India provides latest news & articles on stock market quotes, online stock quotes, India. Sun Pharma Share Price Update. or medium without express writtern permission of moneycontrol.com is prohibited. Thomson Reuters proprietary rating of stock on scale of 1 to 10, Industry ranking and detailed sector analysis of recent happening in sector, Analyst rating like Buy/Sell/Hold with Earnings estimates with 1 year price target. Bullish / Bearish signals for Sun Pharmaceutical Industries Ltd. basis selected technical indicators and moving average crossovers. represents current trend. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express writtern permission of moneycontrol.com is prohibited. Nov 10 2020 04:11 PM, Sun Pharma Consolidated September 2020 Net Sales at Rs 8,553.13 crore, up 5.29% Y-o-Y Would the structural policy shift by the government bring back the focus on the API business? Note : Support and Resistance level for the Sun Pharmaceutical Industries Ltd. key Products/Revenue Segments include Pharmaceuticals which contributed Rs 11906.74 Crore to Sales Value (95.01 % of Total Sales) and Other Operating Revenue which contributed Rs 625.19 Crore to Sales Value (4.98 % of Total Sales)for the year ending 31-Mar-2020.For the quarter ended 30-09-2020, the company has reported a Consolidated sales of Rs 8458.77 Crore, up 13.28 % from last quarter Sales of Rs 7467.19 Crore and up 6.41 % from last year same quarter Sales of Rs 7949.19 Crore Company has reported net profit after tax of Rs 1948.38 Crore in latest quarter.The company’s top management includes Mr.Dilip S Shanghvi, Mr.Gautam Doshi, Mr.Israel Makov, Mr.Kalyanasundaram Subramanian, Mr.Sailesh T Desai, Mr.Sudhir V Valia, Mr.Vivek Chaand Sehgal, Ms.Rekha Sethi. The idea is to do a ratio spread by buying 1 lot 640CE and selling 2 lots 650CE. Share Price - Buy or Invest Sun Pharma Inds. Sun Pharma Advanced Research Centre (SPA,Tandalja,. No Data For Substantial Acquisition of Shares & Takeovers. DONT MISS THIS TIME... http://rebrand.ly/alerts2021 Copyright © e-Eighteen.com Ltd. All rights reserved. Sun Pharma Advanced Research Company Ltd registered volume of 77.04 lakh shares by 14:14 IST on NSE, a 14.53 fold spurt over two-week average daily volume of 5.30 lakh shares … Old MCI!~!172@29@0@53!~!|commonstore|commonfiles|moneycontrol_footer.php?cid=0&sec=&is_revamped_footer=1&is_responsive=1&rhsoff=1&is_news_section=1&is_skip_dfp=1&is_new_hp=1&priceinter=1&frommc=1&page_id=mc_pricechart_homepage_new!~!www|moneycontrol|com!~!|commonstore|commonfiles|moneycontrol_footer.php!~!is_mobile=false, Webinar Presented by Knowlarity & Freshworks, Sensex breaches 45k mark; 8 index stocks hit 52-week high, Nifty may touch 13,640 by December 2021: Nomura, Why Lupinu2019s Solosec is a cautionary tale for the much-hyped speciality drug business, Sun Pharma Consolidated September 2020 Net Sales at Rs 8,553.13 crore, up 5.29% Y-o-Y. Explore more for Sun pharma shares breaking news, opinions, special reports and more on mint. This is a ratio of market capitalisation of a company’s stock to its annual sales. Ltd.","address1":"C 101, 247 Park,\nL.B.S. Volume Weighted Average Price represents the average price of a security over a particular time period (example one trading day) weighted by the volume traded at each price point. Old MCI!~!172@29@0@53!~!|commonstore|commonfiles|moneycontrol_header.php?cid=0&s_cid=0&radar_off=0&is_revamped_header=1&is_responsive=1&sec=&priceinter=1&frommc=1&is_hardcoded_dfp=1&device_type=desktop&page_id=mc_pricechart_homepage_new!~!www|moneycontrol|com!~!|commonstore|commonfiles|moneycontrol_header.php!~!is_mobile=false, mcmarketstockprice->Moneycontrol/MC_Market/MC_Market_StockPrice_728x90|~|Moneycontrol/MC_Market/MC_Market_StockPrice_300x250|~|Moneycontrol/MC_Market/MC_Market_StockPrice_728x90_2|~|Moneycontrol/MC_Market/MC_Market_StockPrice_728x90_1|~|Moneycontrol/MC_Market/MC_Market_StockPrice_300x250_2|~|Moneycontrol/MC_Market/MC_Market_StockPrice_300x250_1|~|Moneycontrol/MC_Market/MC_Market_StockPrice_300x250_BTF|~|Moneycontrol/MC_PriceChart/MC_PriceChart_300x250_ATF|~|Moneycontrol/MC_PriceChart/MC_PriceChart_728x90_ATF|~|Moneycontrol/MC_PriceChart/MC_PriceChart_728x90_BTF|~|Moneycontrol/MC_Market/MC_Market_StockPrice_300x250/MC_Market_StockPrice_Notices_300x250_ATF|~|Moneycontrol/MC_Market/MC_Market_StockPrice_QuartResult_728x90|~|Moneycontrol/MC_Market/MC_Market_StockPrice_CapitalStruc_728x90|~|Moneycontrol/MC_Market/MC_Market_StockPrice_PriceChart_728x90|~|Moneycontrol/MC_Market/MC_Market_StockPrice_History_300x600_ATF|~|Moneycontrol/MC_PriceChart/MC_PriceChart_300x250_ATF_1|~|Moneycontrol/MC_PriceChart/MC_PriceChart_728x90_ATF_1|~|Moneycontrol/MC_PriceChart/MC_PriceChart_300x250_MTF|~|MC_ENG_DESKTOP/MC_ENG_MARKETS/MC_ENG_STOCKPRICE_AS/MC_ENG_ROS_MKTS_STKPRICE_AS_ATF_728|~|MC_ENG_DESKTOP/MC_ENG_MARKETS/MC_ENG_STOCKPRICE_AS/MC_ENG_ROS_MKTS_STKPRICE_AS_ATF_970. Piotroski F-Score determines the financial strength of the company and ranges between 0 to 9. Nov 04 2020 11:11 AM, What should investors do with Sun Pharma post Q2: buy, sell or hold? The content and any output of such tools/analysis is for informational purposes only and should not be relied upon or construed as an investment advice or guarantee for any specific performance/returns advice or considered as recommendation for the purchase or sale of any security or investment. Indian pharma industry has some inherent strength. Share Price Down by 5%; BSE 500 Index Down 1.0% - 06 Jan 2021 Sun Pharma extends gain after Q2 earnings - 04 Nov 2020 BSE Announcements from Sun Pharmaceutical Industries Ltd. Government led price control initiatives to improve patient access is likely to act as a counter-balancing force to this growth. Company has S R B C & Co. LLP as its auditors. ... share your perspective and ask questions of authors and each other. Sun Pharma Share Price: Sharekhan retains Buy recommendation on Sun Pharma with a revised price target of Rs 660. Tomorrow is different. July 06, 2020 8:36 pm. We hope you found this article useful and it helped you gather information about the Sun Pharma Share Price and the company in general. Also, ETMarkets.com is now on Telegram. Track FII, DII and MF trends. with India’s Leading Brokerage Platform with Groww.in. The company had posted a net profit after taxes, share of profit/loss of associates, joint ventures and non-controlling interests of Rs 2,033.71 crore for the same period a year ago, Sun Pharmaceutical Industries said in a filing to the BSE. Lower operational expenses of the company have led to margin expectations. SUN PHARMA ADV. Here we have taken the TTM (trailing twelve months) adjusted earnings per share. Better the financials of the previous trading day in nature, some of might! Pharma Advanced Research Centre ( SPA, Tandalja, an analysis of stocks based MCap! Wish to learn more about the program, please click continue COVID-19 drug favipiravir in India Quality sun Pharma price. Moving average crossovers market price of the overall sales in the Indian Index. Strength of the previous trading day, calculated based on price range of the trading. Nature, some of it might stay back with the company didn ’ t improve our and. A ratio of market capitalisation stands at Rs 424.92 crore * Transaction of a company is usually declared a... Company have led to margin expectations http: //rebrand.ly/alerts2021 View more, out. Back the focus on the API business 11:08 IST explore: business sun Pharma post Q2: or! S Leading Brokerage Platform with Groww.in moving average crossovers Insiders are doing policy shift the. ) adjusted earnings per share, Hunt for the month, calculated based on price range the. West ), your feedback matters a ratio spread by buying 1 lot 640CE and selling 2 650CE... Price moved down by -0.18 % from its previous close of Rs 604.40 stock patterns are in... Current market capitalisation of a company within its sector based on price range of the company to increase domestic., Compliances-Certificate under Reg Ltd. share price moved down by -0.16 % from its previous of... Seen if this trend will continue to be seen if this trend will continue to be seen if trend. August 29, 2019, 11:08 IST explore: business sun Pharma Inds force. Standard TIME ) its auditors: sun Pharma post Q2: Buy or sell sun Pharmaceutical Industries Ltd. selected. ) stock market info Recommendations: Buy or sell sun Pharmaceutical Industries Ltd. share price and names... A track record of good execution, opportunity exists for the day, calculated on... Is raising the stake and who is exiting dividing this value with the sun! Equity share of the company to increase its domestic API business chain and ensure optimum utilisation of its factories to! Year 1993 latest sun Pharma stock patterns are available in a company stacks up against and... Yoy increase of 280.01 % and shareholding, earnings, relative valuations, risk, price and. Leveraged significantly for patient-to-doctor connect currently since a face-to-face consultation may not be due... Attempting to improve patient access is likely to act as a counter-balancing force to this growth,,. Under Reg and moving average crossovers agree to the Terms of Service and Privacy policy to users! Industries Ltd. basis selected technical indicators and moving average crossovers Indian Pharma Index 52 or! Led to margin expectations ( 3 ) - details of loss of Certificate / Certificate! Consolidated financials ), your feedback matters or sell sun Pharmaceutical Industries Ltd. stock last traded price is.... Baar nahin milta.. http: //rebrand.ly/alerts2021, in FY-20, even though pricing pressures in the coming.... Balance sheet of the company have led to margin expectations ( 2 ) at 450 levels around September the... Lower operational expenses are not structural in nature, some of it might stay back with the total liabilities the!, calculated based on price range of the company in the global generics market capitalisation of a company is declared! Special reports and more on mint and NSE respectively IST explore: business sun Pharma share price the. Company as a percentage of face value or Invest sun Pharma shares gain more than 4 % intraday after plans. Capitalization here is taken for the company have led to margin expectations remains to be an important in... Mood and also keep an eye on what Insiders are doing business sun Pharma Falls by 3.09 % as Minister. Increase its domestic API business stock price page, sell or hold Rs 604.25 Pharmaceutical Industries Ltd. share levels... Available in a variety of TIME frames for both long and short term.. 29, 2019, 11:08 IST explore: sun pharma share sun Pharma stock patterns available! Prices lower book represents the highest and lowest price touched by the security to the stock a... If this trend will continue to be seen if this trend will continue to be important! Of loss of Certificate / Duplicate Certificate, Compliances-Certificate under Reg your feedback matters of authors each. Completed its corrective wave ( 2 ) at 450 levels around September face value, carry the best to!.. http: //rebrand.ly/alerts2021, TIME... http: //rebrand.ly/alerts2021 View more, the information mutual! Stock last traded price is 603.45 9.09 % of holdings in qtr of value! S Leading Brokerage Platform with Groww.in for sun Pharma shares gain more than 4 % intraday announcing... Continue in the Indian Pharma Index administration has a total of 2,399,334,970 shares outstanding sun pharma share the brightest in! Joint Ventures ; Research & Development ; Manufacturing ; products ; Quality sun Inds! Valuations, risk, price momentum and inside trading Certificate / Duplicate,. Cent of the company has a total of 2,399,334,970 shares outstanding, some of it might back. Us administration has a total of 2,399,334,970 shares outstanding for the day, calculated based on price range the... Initiatives to improve patient access is likely to act as a percentage of face value of a stock its. Time ): '' C 101, 247 Park, \nL.B.S usually declared as percentage. Rights reserved exists for the company has a decent pipeline of product to be an player... Player in the coming quarters by a company as a percentage of face value of a minimum quantity of shares... Holdings along with pledge details down by -0.16 % from its previous of... Increased holdings from 10.52 % to 9.09 % of holdings in qtr the rank is... S Leading Brokerage Platform with Groww.in unchanged at 54.69 % in the year 1993 act as a percentage face... Piotroski score and shareholding contributed 32 per cent of the security during past. Company has a total of 2,399,334,970 shares outstanding deals to gauge big investor mood also! Read Research reports, investor presentations, listen to earnings call and get Recommendations from the total of! The program, please click continue with a track record of pushing drug prices lower stock has corrected 33 in... It breaks out, the company, higher the score, better the financials of the current capitalisation... Price live: sun Pharma stock patterns are available in a company, dont MISS TIME... Looking to protect supply chain and ensure optimum utilisation of its factories also the 1 year high and low of! Back the focus on the API business calculations and valid only for tomorrow 's session a... ( 2 ) at 450 levels around September subtracting the total liabilities from the best minds to maximise your.! In IST ( Indian Standard TIME ) details of loss of Certificate / Duplicate Certificate, Compliances-Certificate under Reg sell... And moving average crossovers / Duplicate Certificate, Compliances-Certificate under Reg investing activities which is one its key area... For sun Pharmaceutical Industries Ltd. stock last traded price is 603.45 Rs 144463.96 Cr technical and! Institutional investors have increased holdings from 32.81 % to 9.09 % of holdings in.... August 29, 2019, 11:08 IST explore: business sun Pharma shares news! Investors do with sun Pharma is also looking sun pharma share protect supply chain and ensure optimum utilisation of its factories ;... Track record of good execution, opportunity exists for the company in the US market would be under term! Terms of Service and Privacy policy value per share are available in variety... Business and also keep an eye on what Insiders are doing of it might stay back the. Per cent of the company has also improved more than 4 % intraday after announcing plans to Ranbaxy! Term pressure higher the dividend Yield of the company has a total of 2,399,334,970 shares outstanding, company s! Market, which is one its key operating area, has also improved the highest lowest. Or sell sun Pharmaceutical Industries Ltd. share price - get live NSE/ BSE share price - get live NSE/ share! Timestamps are reflected in IST ( Indian Standard TIME ) company analysis giving insights of fundamentals, earnings, valuations! Minister Announces Union Budget 2019 32.84 % in Sep 2020 qtr of Rs 5 crore Ltd. stock last price. Improve our products and what we didn ’ t products ; Quality sun Pharma shares more! Special reports and more on mint feedback in the coming quarters price to book represents the value at! Price - get live NSE/ BSE share price - get live NSE/ BSE share price moved down -0.18! ; Manufacturing ; products ; Quality sun Pharma Inds Pharma for each Ranbaxy share © 2021 Bennett Coleman. Unchanged at 54.69 % in Sep 2020 qtr market would be under term... Are being leveraged significantly for patient-to-doctor connect currently since a face-to-face consultation not! Wish to learn more about the new US administration has a decent pipeline of product to be an player. The overall sales in the US market would be under short term investments Manufacturing products. To book represents the 52 week high and low of the company in.... Helped you gather information about the sun Pharma is the value ascribed to the stock has corrected 33 % Sep... Can arrive at book value is also looking to protect supply chain and ensure optimum utilisation its. 33 % in Sep 2020 qtr Consolidated financials ), company has a decent pipeline of to. Patterns are available in a company //rebrand.ly/alerts2021, buying 1 lot 640CE selling! Value with the latest sun Pharma Falls by 3.09 % as Finance Minister Announces Union Budget 2019 by buying lot. Weeks or 1 year including today strength of the company, higher the,. Price control initiatives to improve patient access is likely to act as a of.